This brand name is authorized in Austria, Estonia, Lithuania, Malta, Romania, Turkey.
The drug LYSTHENON contains one active pharmaceutical ingredient (API):
1
|
UNII
I9L0DDD30I - SUCCINYLCHOLINE CHLORIDE
|
|
Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M03AB01 | Suxamethonium | M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AB Choline derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1014332 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1019806, 1089072 |
| MT | Medicines Authority | AA565/80501 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W61717001, W61717002 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699638754540 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.